Aarkstore announce a new report “Contract Manufacturing Strategies: Market developments, technology transfer and key success factor” due to its vast collection report of market research. Manufacturing Contract manufacturing strategies of the current medications is generally 25% of company costs and achieving agility in the production process has become essential for pharmaceutical companies hoping to align their supply chains with constant changes in global demand for products. In addition to efficiency gains by providing cost, capacity and time-to-market agencies contract manufacturing (CMO) can provide innovative, state-of-the-art processes and production technologies to support the rapid transfer of product technology R & D to commercial manufacturing. However, effective management of the CMO sponsor relationship is critical not only to satisfy regulatory requirements amid growing concerns about quality control, but also meet the overall business objective of the project. ‘Contract Manufacturing Strategies: Market developments, technology transfer and key success factors’ is a new report explores the future market of contract manufacturing with a detailed analysis of emerging drivers and restraints, business models and production strategies. The potential benefits and risks of contract manufacturing are assessed and key strategies for the selection and effective management of the CMO successful relationship are identified . The report also examines the latest laws of contract FDA to determine the most effective measures to ensure regulatory compliance and assesses the rapidly expanding markets of India and China to discover their potential and growth regulator Outlook. Understanding how the CMO market will develop over the period 2008-2013, identify emerging manufacturing strategies / regulatory issues and assess the potential growth of outsourcing in India and China with this report. .. Some of the main conclusions of this report… • The CMO market worldwide will be worth $ 20. 5 billion by the end of 2008, having spent $ 12. 8 billion in 2002. Growth sustained in this sector is expected to continue, with a projected CAGR of 10%. • Contract Research and Manufacturing Organization (CRAM) have emerged as models of key business future, engaging in both contract research and manufacturing. These hybrids can offer molecule synthesis from the milligram to the multi-hundred tons scale. • 29% of manufacturing output should be produced by third by 2010, as large companies continue to cut back on production and focus on core competencies. Major players including AstraZeneca, Roche, Pfizer and Schering are currently undertaking manufacturing strategy reviews to enhance profitability. • CMOS-based Asia increased their contract service revenues by 44 % over the period 2006-2007. The low-cost competition from Asia will have a decisive influence on the CMO industry over the next 5-10 years. • biologics manufacturing has become an area of Action preferred for CMOS. The number of new biotech drug to progress through development far exceeds the number of conventional drugsTop five reasons to order your copy today • Assess the future of the sourcing and manufacturing strategies with the analysis of this report the structural evolution of the industry CMO, new capabilities and business model of five forecasts of market growth this year. • Explore the potential outsourcing of ‘India and China and measure the impact of low cost manufacturing by using this report to assess the future growth of managers, the potential regulatory, patent and recent security issues and a case study of Heparin producers in China. • Identify the latest legislation on contract manufacturing of FDA and understand how to ensure regulatory compliance by examining current regulatory requirements for both sponsors and subcontractors. • Understand the key success factors for establishing successful partnerships with CMO detailed analysis of the report of the multi-step sourcing process for CMOS and determine the essential criteria for CMO selection and effective relationship management. • Assess the risks and challenges of major projects for manufacturing contract by gaining insights into the potential harms and costs. Key issues examined in this report… • Importance tech-transfer/scale-up. Technology transfer is an effective key element in the success of a project contract manufacturing, but it is immersed in uncertainty. Delays and costs both vary dramatically, and together with the scale up capacity, which is a decisive factor in determining the fit between a client and a CMO. • Ensuring regulatory compliance. The client company is deemed to be responsible for the manufacturing process, whether external or internal. All facilities involved in manufacturing / testing of a drug must comply with cGMP that apply to their operations. • Effective management of risks. Although the risk of failure of certain medications is assumed by the client company, the economic model of the COM ‘s is not designed to absorb high levels of risk. It is therefore essential for the client company to implement a wide range of risk mitigation tactics. • Offshoring to India / China. Asia continues to ‘ expand outsourcing capabilities to offer large cost savings and revenue growth opportunities, however many CMOs in the region have done nothing to demonstrate the levels of regulatory compliance expected by clients. Answers to your questions… • How the CMO market develop over the period 2008-11? • What are the key factors influencing ‘buy or make “decisions in biomanufacturing • what are the market drivers and current constraints of contract biomanufacturing market? • What is the forecast global manufacturing capacity and growth rates for microbial fermentation and mammalian cell culture expressionsystems on 2006-2011 • What types of risks and challenges inherent in a manufacturing project outsourced? • What are key selection criteria and success factors for manufacturing organizations under contract • What are the critical issues affecting technology transfer & scale-up • How the India and China influence the CMO market World • What is the long-term future of domestic manufacturing? For more information, please visit: http:/ / www. aarkstore. com / reports / Contract-Manufacturing-Strategies-Market-development-technology-transfer-and-key-success-factors-14405. htmlOr email us at press @ aarkstore. com or call 919,272,852,585 special offer until December 31, 2009